Synopsys Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Synopsys Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Synopsys, Inc. (NASDAQ:SNPS) is set to release earnings results for its second quarter, after the closing bell on Wednesday.
新思科技公司（納斯達克股票代碼：SNPS）將在週三收盤後發佈第二季度業績。
Analysts expect the Sunnyvale, California-based company to report quarterly earnings at $3.05 per share, up from $2.54 per share in the year-ago period. Synopsys is expected to post revenue of $1.51 billion, according to data from Benzinga Pro.
分析師預計，這家總部位於加利福尼亞州森****爾的公司將公佈的季度收益爲每股3.05美元，高於去年同期的每股2.54美元。根據Benzinga Pro的數據，新思科技預計將實現15.1億美元的收入。
On May 6, Synopsys entered into a definitive agreement with Clearlake Capital Group, L.P. and Francisco Partners, two global private equity firms, to sell its Software Integrity Group business.
5月6日，新思科技與兩家全球私募股權公司Clearlake Capital Group, L.P. 和Francisco Partners簽訂了出售其軟件誠信集團業務的最終協議。
Synopsys shares fell 0.5% to close at $571.53 on Tuesday.
週二，新思科技股價下跌0.5％，收於571.53美元。
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Benzinga的讀者可以在分析師股票評級頁面上訪問最新的分析師評級。讀者可以按股票行情、公司名稱、分析公司、評級變化或其他變量進行排序。
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
讓我們來看看Benzinga最準確的分析師在最近一段時間對該公司的評級。
- Needham analyst Charles Shi reiterated a Buy rating with a price target of $660 on March 22. This analyst has an accuracy rate of 76%.
- Rosenblatt analyst Blair Abernethy reiterated a Buy rating with a price target of $615 on March 21. This analyst has an accuracy rate of 79%.
- Baird analyst Joe Vruwink maintained an Outperform rating and boosted the price target from $624 to $640 on Feb. 22. This analyst has an accuracy rate of 76%.
- Stifel analyst Ruben Roy maintained a Buy rating with a price target of $620 on Jan. 17. This analyst has an accuracy rate of 79%.
- B of A Securities analyst Vivek Arya maintained a Buy rating with a price target of $650 on Jan. 4. This analyst has an accuracy rate of 83%.
- Needham分析師查爾斯·施在3月22日重申了買入評級，目標股價爲660美元。這位分析師的準確率爲76％。
- 羅森布拉特分析師布萊爾·阿伯內西在3月21日重申了買入評級，目標股價爲615美元。這位分析師的準確率爲79％。
- 貝爾德分析師喬·弗魯溫克維持跑贏大盤的評級，並於2月22日將目標股價從624美元上調至640美元。這位分析師的準確率爲76％。
- Stifel分析師魯本·羅伊在1月17日維持買入評級，目標股價爲620美元。這位分析師的準確率爲79％。
- Bof A證券分析師維維克·艾莉亞在1月4日維持買入評級，目標股價爲650美元。這位分析師的準確率爲83％。
Read This Next: Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose
接下來閱讀這篇文章：吉姆·克萊默稱這隻醫療保健股爲 “值得關注的規格”，建議避開 Canada Goose
譯文內容由第三人軟體翻譯。